stockrowSyra Health Corp.
SYRA Healthcare Medical Care Facilities
Syra Health Corp.’s revenue for fiscal 2025 (year ended December 2025) was $7.2 million, down 9.47% from fiscal 2024.
- Revenue
- +51.5%
- EPS
- +221.5%
- Free cash flow
- +235.8%
Quarter to September 2026, against a year earlier
Follow SYRA
Alert me
Syra Health Corp. (SYRA) Altman Z-score
Syra Health Corp.'s Altman Z-score for fiscal 2025 is −1.58, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | −1.58 | (0.24) |
| FY2024 | −1.34 | (3.30) |
| FY2023 | 1.95 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.74 | — | 0.89 | |
| Retained earnings / total assets | (3.51) | — | −4.91 | |
| EBIT / total assets | (0.33) | — | −1.08 | |
| Market value of equity / total liabilities | 1.50 | — | 0.90 | |
| Sales / total assets | 2.61 | — | 2.61 | |
| Altman Z-score | Distress zone | −1.58 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −5.47 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| BTMD biote Corp. compare | 2.6× |
| AMS American Shared Hospital Services compare | 0.7× |
| NIVF NewGenIvf Group Limited compare | −0.3× |
| RHEP Adcare Health Systems Inc compare | −0.9× |
| CCM Concord Medical Services Holdings Limited compare | −1.2× |
| PIII P3 Health Partners Inc. compare | −1.3× |
| DCGO DocGo Inc. compare | −1.4× |
| SYRA Syra Health Corp. | −1.6× |
| NVOS Novo Integrated Sciences, Inc. compare | −4.4× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets